Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Besada

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Collection of Czechoslovak Chemical Communications|November 24, 2021
NUCLEOSIDE PRODRUGS OF A<sub>3</sub> ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTSPedro Besada, Liaman K Mamedova, Krishnan K Palaniappan, et al.
Journal of Medicinal Chemistry|February 17, 2007
Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphateAndrei A Ivanov, Hyojin Ko, Liesbet Cosyn, et al.
Bioorganic Chemistry|September 15, 2020
Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapyFernanda Rodríguez-Enríquez, María Carmen Costas-Lago, Pedro Besada, et al.
Biomolecules|December 24, 2021
The New Pharmacological Chaperones PBXs Increase α-Galactosidase A Activity in Fabry Disease Cellular ModelsPedro Besada, María Gallardo-Gómez, Tania Pérez-Márquez, et al.
Experimental Eye Research|November 3, 2009
Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across speciesZhao Wang, Chi Wai Do, Marcel Y Avila, et al.
Biochemistry|June 5, 2007
Probing the binding site of the A1 adenosine receptor reengineered for orthogonal recognition by tailored nucleosidesKrishnan K Palaniappan, Zhan-Guo Gao, Andrei A Ivanov, et al.
Bioorganic & Medicinal Chemistry|June 3, 2008
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonistsHyojin Ko, Rhonda L Carter, Liesbet Cosyn, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Collection of Czechoslovak Chemical Communications|November 24, 2021
NUCLEOSIDE PRODRUGS OF A<sub>3</sub> ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTSPedro Besada, Liaman K Mamedova, Krishnan K Palaniappan, et al.
Journal of Medicinal Chemistry|February 17, 2007
Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphateAndrei A Ivanov, Hyojin Ko, Liesbet Cosyn, et al.
Bioorganic Chemistry|September 15, 2020
Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapyFernanda Rodríguez-Enríquez, María Carmen Costas-Lago, Pedro Besada, et al.
Biomolecules|December 24, 2021
The New Pharmacological Chaperones PBXs Increase α-Galactosidase A Activity in Fabry Disease Cellular ModelsPedro Besada, María Gallardo-Gómez, Tania Pérez-Márquez, et al.
Experimental Eye Research|November 3, 2009
Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across speciesZhao Wang, Chi Wai Do, Marcel Y Avila, et al.
Biochemistry|June 5, 2007
Probing the binding site of the A1 adenosine receptor reengineered for orthogonal recognition by tailored nucleosidesKrishnan K Palaniappan, Zhan-Guo Gao, Andrei A Ivanov, et al.
Bioorganic & Medicinal Chemistry|June 3, 2008
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonistsHyojin Ko, Rhonda L Carter, Liesbet Cosyn, et al.
Pageof 4